Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004323 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia
A Phase 2 study of Aplastic Anemia, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00004323 is a Phase 2 study of Aplastic Anemia that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 10 participants, below the 42-participant average among 23 other Aplastic Anemia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00004323, a Phase 2 study of Aplastic Anemia, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: I. Evaluate the efficacy of related, HLA-identical bone marrow transplantation following cyclophosphamide (CTX) and antithymocyte globulin in patients with aplastic anemia. II. Evaluate the efficacy of related, HLA-nonidentical bone marrow transplantation following CTX and total-body irradiation/total-lymphoid irradiation in patients with aplastic anemia.
Conditions Studied
Interventions
- DRUG cyclophosphamide
- DRUG methotrexate
- DRUG mesna
- DRUG cyclosporine
- DRUG anti-thymocyte globulin
Study Locations (1)
California
- Center for Health Sciences - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 1995-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004323
The ClinicalTrials.gov registry entry for NCT00004323 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 42-participant average among 23 other Aplastic Anemia trials with a reported enrollment target (76% lower). The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aplastic Anemia appearing as the primary indexed condition, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00004323 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00004323 about?
NCT00004323 is a clinical study titled "Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia". OBJECTIVES: I. Evaluate the efficacy of related, HLA-identical bone marrow transplantation following cyclophosphamide (CTX) and antithymocyte globulin in patients with aplastic anemia. II. Evaluate the efficacy of related, HLA-nonidentical bone marrow transplantation following CTX and total-body ir...
What is the current status of trial NCT00004323?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 1995-02.
What conditions does trial NCT00004323 study?
This clinical trial studies the following conditions: Aplastic Anemia.
What interventions are being tested in trial NCT00004323?
The interventions under investigation include: cyclophosphamide (DRUG), methotrexate (DRUG), mesna (DRUG), cyclosporine (DRUG), anti-thymocyte globulin (DRUG).
Who is sponsoring clinical trial NCT00004323?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004323 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aplastic Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
RECRUITING · Phase 2
-
Two Step Haplo With Radiation Conditioning
RECRUITING · Phase 2
-
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
RECRUITING · Phase 2
-
A Study of Emapalumab for Pediatric Aplastic Anemia
RECRUITING · Phase 2
-
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
RECRUITING · Phase 2
-
Haploidentical HCT for Severe Aplastic Anemia
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.